Skip to main content
. Author manuscript; available in PMC: 2019 Mar 2.
Published in final edited form as: Prog Neuropsychopharmacol Biol Psychiatry. 2017 Nov 9;82:242–248. doi: 10.1016/j.pnpbp.2017.11.007

Table 1.

Study and subject information of the studies included in the current meta-analysis.

Study ASD TD ↓↑

n F age (y) IQ n F age (y) IQ
1 Bakhtiari 2012a 16 1 15.5 108.1 18 1 15.5 111.8
2 Bamea-Goraly 2004 7 0 14.6 101 9 0 13.4 107
3 Bloemen 2010 13 0 39 110 13 0 37 115
4 Cheng 2010 25 0 13.71 101.6 25 0 13.51 109.04 ↓↑
5 Cheung 2009 13 1 9.3 99.5 14 1 9.9 111.9 ↓↑
6 Fitzgerald 2016 45 0 15.91 109.5 45 0 16.55 115
7 Itahashi 2015 46 0 30.21 106 46 0 30.54 109.22
8 Ke 2009 12 0 8.75 100.6 10 0 9.4 99.83 ↓↑
9 Keller 2007 34 0 18.9 102 31 0 18.9 109.5
10 Kleinhans 2013 25 9 21.29 109.88 28 6 21.31 113.25
11 Mueller 2013 12 3 35.5 111.3 12 4 33.3 110.8
12 Nickel 2017 30 11 35.4 124.5 30 11 35.53 123.63
13 Noriuchi 2010 7 1 13.96 92.71 7 1 13.36 116.43
14 Thakkar 2008 12 2 30 116 14 6 27 114 ↓↑

↓ and ↑ indicate a study reported clusters with increased or increased FA in ASD compared with TD, respectively.

a

Bakhtiariet al. (2012) recruited two age groups, but only adolescent group showed statistically significant results. Therefore, only adolescent groups of patients and controls were included in the current analysis.